286 related articles for article (PubMed ID: 36167923)
1. Valvular heart disease: shifting the focus to the myocardium.
Ajmone Marsan N; Delgado V; Shah DJ; Pellikka P; Bax JJ; Treibel T; Cavalcante JL
Eur Heart J; 2023 Jan; 44(1):28-40. PubMed ID: 36167923
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular magnetic resonance imaging to assess myocardial fibrosis in valvular heart disease.
Podlesnikar T; Delgado V; Bax JJ
Int J Cardiovasc Imaging; 2018 Jan; 34(1):97-112. PubMed ID: 28642994
[TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis in asymptomatic patients undergoing surgery for mitral and aortic valve regurgitation.
Fragasso G; Sanvito F; Monaca G; Ardizzone V; De Bonis M; Pappalardo F; Smart C; Montanaro C; Lapenna E; Calabrese MC; Castiglioni A; Benussi S; Maisano F; Zangrillo A; Ambrosi A; Doglioni C; Alfieri O; Margonato A
J Cardiovasc Med (Hagerstown); 2022 Aug; 23(8):505-512. PubMed ID: 35904996
[TBL] [Abstract][Full Text] [Related]
4. A prospective study examining the role of myocardial Fibrosis in outcome following mitral valve repair IN DEgenerative mitral Regurgitation: rationale and design of the mitral FINDER study.
Liu B; Edwards NC; Neal DAH; Weston C; Nash G; Nikolaidis N; Barker T; Patel R; Bhabra M; Steeds RP
BMC Cardiovasc Disord; 2017 Nov; 17(1):282. PubMed ID: 29166877
[TBL] [Abstract][Full Text] [Related]
5. Focus on Diagnosis and Prognosis to Guide Timing of Intervention in Valvular Heart Disease.
Stassen J; Galloo X; van der Bijl P; Bax JJ
Curr Cardiol Rep; 2022 Oct; 24(10):1407-1416. PubMed ID: 35925514
[TBL] [Abstract][Full Text] [Related]
6. Timing of intervention in asymptomatic patients with valvular heart disease.
Baumgartner H; Iung B; Otto CM
Eur Heart J; 2020 Dec; 41(45):4349-4356. PubMed ID: 32901279
[TBL] [Abstract][Full Text] [Related]
7. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
[TBL] [Abstract][Full Text] [Related]
8. [The best of valvular heart disease in 2006].
de Gevigney G;
Arch Mal Coeur Vaiss; 2007 Jan; 100 Spec No 1():19-28. PubMed ID: 17405561
[TBL] [Abstract][Full Text] [Related]
9. Advanced cardiac MRI techniques for evaluation of left-sided valvular heart disease.
Blanken CPS; Farag ES; Boekholdt SM; Leiner T; Kluin J; Nederveen AJ; van Ooij P; Planken RN
J Magn Reson Imaging; 2018 Aug; 48(2):318-329. PubMed ID: 30134000
[TBL] [Abstract][Full Text] [Related]
10. Exercise testing and stress imaging in valvular heart disease.
Henri C; Piérard LA; Lancellotti P; Mongeon FP; Pibarot P; Basmadjian AJ
Can J Cardiol; 2014 Sep; 30(9):1012-26. PubMed ID: 25151284
[TBL] [Abstract][Full Text] [Related]
11. [When is surgery needed for minimally symptomatic or asymptomatic acquired valvulopathy?].
Acar J; Michel PL; de Gevigney G
Presse Med; 2000 Nov; 29(34):1867-75. PubMed ID: 11709821
[TBL] [Abstract][Full Text] [Related]
12. [Is Na+Ca(2+) exchanger expression altered in the endomyocardium of patients with chronic heart valve diseases parallel to myocardial dysfunction?].
Piper C; Bilger J; Henrichs EM; Wudel E; Schultheiss HP; Horstkotte D; Dörner A
Z Kardiol; 2000 Aug; 89(8):682-90. PubMed ID: 11013973
[TBL] [Abstract][Full Text] [Related]
13. Advanced imaging in valvular heart disease.
Bax JJ; Delgado V
Nat Rev Cardiol; 2017 Apr; 14(4):209-223. PubMed ID: 28127033
[TBL] [Abstract][Full Text] [Related]
14. Cardiac remodeling in aortic and mitral valve disease: a simulation study with clinical validation.
Maksuti E; Westerhof BE; Ugander M; Donker DW; Carlsson M; Broomé M
J Appl Physiol (1985); 2019 May; 126(5):1377-1389. PubMed ID: 30730809
[TBL] [Abstract][Full Text] [Related]
15. Valvular Heart Disease in Adults: Etiologies, Classification, and Diagnosis.
Hollenberg SM
FP Essent; 2017 Jun; 457():11-16. PubMed ID: 28671804
[TBL] [Abstract][Full Text] [Related]
16. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
[TBL] [Abstract][Full Text] [Related]
17. Associations of aortic and mitral regurgitation with body composition and myocardial energy expenditure in adults with hypertension: the Hypertension Genetic Epidemiology Network study.
Palmieri V; Bella JN; Arnett DK; Oberman A; Kitzman DW; Hopkins PN; Rao DC; Roman MJ; Devereux RB;
Am Heart J; 2003 Jun; 145(6):1071-7. PubMed ID: 12796765
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Nursing Management for Valvular Disease.
Lee S
Crit Care Nurs Clin North Am; 2019 Mar; 31(1):31-38. PubMed ID: 30736933
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Magnetic Resonance in Valvular Heart Disease: Assessment of Severity and Myocardial Remodeling.
Malahfji M; Shah DJ
Methodist Debakey Cardiovasc J; 2020; 16(2):106-113. PubMed ID: 32670470
[TBL] [Abstract][Full Text] [Related]
20. High sensitivity troponin and valvular heart disease.
McCarthy CP; Donnellan E; Phelan D; Griffin BP; Enriquez-Sarano M; McEvoy JW
Trends Cardiovasc Med; 2017 Jul; 27(5):326-333. PubMed ID: 28256378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
